Search results
Results from the WOW.Com Content Network
When the U.S. government closed the border with Mexico to non-essential travel in March 2020 during the COVID-19 pandemic, drug traffickers switched from cocaine and heroin to fentanyl, which was easier to transport undetected in the small number of "essential" vehicles allowed to cross. American deaths from fentanyl overdoses doubled between ...
In 2022, cross-border trade between Canada, Mexico and the U.S. amounted to an estimated $1.8 trillion, according to the U.S. Trade Representative’s office. Mexico is also a key partner of the U ...
War on drugs A U.S. government PSA from the Alcohol, Drug Abuse, and Mental Health Administration with a photo image of two marijuana cigarettes and a "Just Say No" slogan Date June 17, 1971 – present (53 years, 8 months, 2 weeks and 3 days) Location Global Status Ongoing, widely viewed as a policy failure Belligerents United States US law enforcement Drug Enforcement Administration US Armed ...
Users of this vaccine passport, the first in Canada, faced fewer COVID-19 public health restrictions. [2] By early July, the demand for the paper vaccine passports temporarily overwhelmed the system. At the same time, the province reached a new "marker in the pandemic"—the COVID-19 vaccines supply exceeded "demand on a daily basis." [2] [44]
OpEd: Importing drugs from Canada to states like Florida and Kentucky makes sense in theory but not in practice.
The Canadian government anticipates that at least 95 per cent of the Canadian population will be able to receive a COVID-19 vaccine by the end of the third quarter of the year, between July and ...
Similarly to many anti-vaccination groups, Vaccine Choice Canada is opposing several measures instituted by public health authorities to limit the spread of the COVID-19 pandemic. Its President repeated some of the most widespread myths about the virus, including that it is no more dangerous than influenza and that developing a vaccine is ...
Health Canada received a submission from Moderna on June 29, 2023, for yet another reformulated COVID-19 vaccine based on the Omicron XBB.1.5 subvariant of SARS-CoV-2. [131] The updated version was tested in a small human trial of 101 participants who had previously received four doses of previous formulations of the Moderna COVID-19 vaccine.